154 related articles for article (PubMed ID: 8329833)
21. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
[TBL] [Abstract][Full Text] [Related]
22. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
[TBL] [Abstract][Full Text] [Related]
23. Long-term follow-up and final height in girls with central precocious puberty treated with luteinizing hormone-releasing hormone analogue nasal spray.
Cacciari E; Cassio A; Balsamo A; Colli C; Cicognani A; Pirazzoli P; Tani G; Brondelli L; Mandini M; Bovicelli L
Arch Pediatr Adolesc Med; 1994 Nov; 148(11):1194-9. PubMed ID: 7921123
[TBL] [Abstract][Full Text] [Related]
24. Luteinizing hormone-releasing hormone analogue (Buserelin) treatment for central precocious puberty: a multi-centre trial.
Werther GA; Warne GL; Ennis G; Gold H; Silink M; Cowell CT; Quigley C; Howard N; Antony G; Byrne GC
J Paediatr Child Health; 1990 Feb; 26(1):4-8. PubMed ID: 2109996
[TBL] [Abstract][Full Text] [Related]
25. [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
Liang Y; Wei H; Zhang JL; Hou L; Luo XP
Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):845-9. PubMed ID: 15631714
[TBL] [Abstract][Full Text] [Related]
26. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
Mansfield MJ; Beardsworth DE; Loughlin JS; Crawford JD; Bode HH; Rivier J; Vale W; Kushner DC; Crigler JF; Crowley WF
N Engl J Med; 1983 Nov; 309(21):1286-90. PubMed ID: 6415479
[TBL] [Abstract][Full Text] [Related]
27. Adrenarche and skeletal maturation during luteinizing hormone releasing hormone analogue suppression of gonadarche.
Wierman ME; Beardsworth DE; Crawford JD; Crigler JF; Mansfield MJ; Bode HH; Boepple PA; Kushner DC; Crowley WF
J Clin Invest; 1986 Jan; 77(1):121-6. PubMed ID: 2935557
[TBL] [Abstract][Full Text] [Related]
28. Precocious puberty.
Neely EK; Crossen SS
Curr Opin Obstet Gynecol; 2014 Oct; 26(5):332-8. PubMed ID: 25144596
[TBL] [Abstract][Full Text] [Related]
29. Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty.
Weise M; Flor A; Barnes KM; Cutler GB; Baron J
J Clin Endocrinol Metab; 2004 Jan; 89(1):103-7. PubMed ID: 14715835
[TBL] [Abstract][Full Text] [Related]
30. [Improvement of expected and final height in girls with central precocious puberty treated with gonadotropin releasing hormone analogues].
Gómez F; Picó AM; Vargas F; Mauri M
Med Clin (Barc); 1996 Nov; 107(18):681-4. PubMed ID: 9082075
[TBL] [Abstract][Full Text] [Related]
31. Consensus statement on the use of gonadotropin-releasing hormone analogs in children.
Carel JC; Eugster EA; Rogol A; Ghizzoni L; Palmert MR; ; Antoniazzi F; Berenbaum S; Bourguignon JP; Chrousos GP; Coste J; Deal S; de Vries L; Foster C; Heger S; Holland J; Jahnukainen K; Juul A; Kaplowitz P; Lahlou N; Lee MM; Lee P; Merke DP; Neely EK; Oostdijk W; Phillip M; Rosenfield RL; Shulman D; Styne D; Tauber M; Wit JM
Pediatrics; 2009 Apr; 123(4):e752-62. PubMed ID: 19332438
[TBL] [Abstract][Full Text] [Related]
32. Clinical review 60: Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty.
Kletter GB; Kelch RP
J Clin Endocrinol Metab; 1994 Aug; 79(2):331-4. PubMed ID: 8045943
[No Abstract] [Full Text] [Related]
33. Selection of children with precocious puberty for treatment with gonadotropin releasing hormone analogs.
Rosenfield RL
J Pediatr; 1994 Jun; 124(6):989-91. PubMed ID: 8201493
[No Abstract] [Full Text] [Related]
34. Diagnosis and treatment of central precocious puberty--can final height be improved? German/Dutch Central Precocious Puberty Study Group.
Sippell WG
Horm Res; 1994; 41 Suppl 2():14-5. PubMed ID: 8088698
[TBL] [Abstract][Full Text] [Related]
35. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
[TBL] [Abstract][Full Text] [Related]
36. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
Leschek EW; Flor AC; Bryant JC; Jones JV; Barnes KM; Cutler GB
J Pediatr; 2017 Nov; 190():229-235. PubMed ID: 29144249
[TBL] [Abstract][Full Text] [Related]
37. [Treatment with LHRH analogues in girls with precocious puberty does not improve final height. Longitudinal study compared with a control group].
Llop-Viñolas D; Vizmanos-Lamotte B; Aresté-Piztzalis A; Fernández-Ballart J; Martí-Henneberg C
Med Clin (Barc); 2001 Jun; 117(4):124-8. PubMed ID: 11472683
[TBL] [Abstract][Full Text] [Related]
38. Adult height in precocious puberty after long-term treatment with deslorelin.
Oerter KE; Manasco P; Barnes KM; Jones J; Hill S; Cutler GB
J Clin Endocrinol Metab; 1991 Dec; 73(6):1235-40. PubMed ID: 1955504
[TBL] [Abstract][Full Text] [Related]
39. Treatment with a gonadotropin-releasing-hormone analog and attainment of full height potential in a male monozygotic twin with gonadotropin-releasing hormone-dependent precocious puberty.
Ishii T; Sato S; Anzo M; Sasaki G; Hasegawa T; Tamai S; Matsuo N
Eur J Pediatr; 1999 Nov; 158(11):933-5. PubMed ID: 10541952
[TBL] [Abstract][Full Text] [Related]
40. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
